Molecular Medicine Today

Ups and downs on the road to an HIV vaccine
pp. 141-142(2)
Author: Senior K.

Rapid update
pp. 142-142(1)
Author: Brooksbank C.

Q fever vaccine on trial for type I diabetes
pp. 143-143(1)
Author: Bonn D.

Human neural stem cells on trial for Parkinson's disease
pp. 144-144(1)
Author: Fricker J.

Connexins link deafness and skin disorders
pp. 145-145(1)
Author: Osborne L.R.

Protective local cytotoxic T lymphocyte responses stimulated by mucosal vaccination
pp. 145-145(1)
Author: Stagg A.J.

Huntingtin toxicity: nucleus or cytoplasm?
pp. 146-146(1)
Author: Lloyd S.

Drug or poison: dosage is everything
pp. 146-146(1)
Author: Ivanov E.

Alphaviruses to the rescue?
pp. 146-146(1)
Author: Hewson R.

Bioanalytical PCR: ready for Prime time? - PCR in Bioanalysis edited by S.J. Meltzer
pp. 147-147(1)
Author: Mariani B.D.

Changing focus: applying antisense to nuclear medicine imaging
pp. 151-151(1)
Author: Hnatowich D.J.

Prenatal gene therapy: can the technical hurdles be overcome?
pp. 152-156(5)
Authors: Senut M.-C.; Gage F.H.

Radiation, DNA damage and cancer
pp. 157-164(8)
Authors: Hall J.; Angele S.

Towards gene therapy of diabetes mellitus
pp. 165-171(7)
Authors: Levine F.; Leibowitz G.

E-cadherin downregulation in cancer: fuel on the fire?
pp. 172-177(6)
Author: Guilford P.

HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story
pp. 178-186(9)
Authors: Hicklin D.J.; Marincola F.M.; Ferrone S.